Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

TYME Announces First Patient Dosed in Metastatic Pancreatic Cancer Treatment Trial

americanpharmaceuticalreviewJanuary 13, 2020

Tag: TYME , metastatic pancreatic cancer , TYME-88-Panc

PharmaSources Customer Service